Therapeutic substitution could reduce US drug spending by nearly 10%, study finds
BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2710 (Published 12 May 2016) Cite this as: BMJ 2016;353:i2710- Michael McCarthy
- Seattle
The routine use of therapeutic substitution—where cheaper, chemically different compounds from the same therapeutic drug class are substituted for higher priced brand name drugs—could reduce US drug spending by nearly 10%, a new study in JAMA Internal Medicine has found.1
Unlike generic substitution—where a generic equivalent of a brand name drug is used—therapeutic substitution replaces the brand name drug with a drug with a different active ingredient but the same therapeutic effect, such as reducing blood pressure …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.